[Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting].

医学 术后恶心呕吐 昂丹司琼 麻醉 恶心 呕吐 止吐药 随机对照试验 甲氧氯普胺 不利影响
作者
Peter Kienbaum,Maximilian S. Schaefer,Stephanie Weibel,Tobias Schlesinger,Patrick Meybohm,Leopold Eberhart,Peter Kranke
出处
期刊:Anaesthesist [Springer Science+Business Media]
标识
DOI:10.1007/s00101-021-01045-z
摘要

The prophylaxis and treatment of postoperative pain to enhance patient comfort has been a primary goal of anesthesiologists for the last decades; however, avoiding postoperative nausea and vomiting (PONV) is, from a patient's perspective, a highly relevant and equally important goal of anesthesia. Recent consensus-based guidelines suggest the assessment of risk factors including female gender, postoperative opioid administration, non-smoking status, a history of PONV or motion sickness, young patient age, longer duration of anesthesia, volatile anesthetics and the type of surgery and reducing the patient's baseline risk (e.g. through the use of regional anesthesia and administration of non-opioid analgesics as part of a multimodal approach). In general, a liberal PONV prophylaxis is encouraged for adult patients and children, which should also be administered when no risk assessment is made. The basis for every adult patient should be a standard prophylaxis with two antiemetics, such as dexamethasone in combination with a 5-HT3 receptor antagonist. In patients at high risk, this should be supplemented by a third and potentially a fourth antiemetic prophylaxis with a different mechanism of action. A recently published comprehensive Cochrane meta-analysis comparing available antiemetic prophylaxes reported the highest effectiveness to prevent PONV for the NK1 receptor antagonist aprepitant (relative risk, RR 0.26), followed by ramosetron (RR 0.44), granisetron (RR 0.45), dexamethasone (RR 0.51) and ondansetron (RR 0.55), thereby revising the dogma that every antiemetic is equally effective. Adverse events of antiemetics were generally rare and reported in less than half of the included studies, yielding a low quality of evidence for these end points. In general, combinations of different antiemetics were more effective than single prophylaxes. In children above 3 years of age, the same principles should be applied as in adults. For these patients, there is a high degree of evidence for the combination of dexamethasone and 5‑HT3 receptor antagonists. When PONV occurs, the consensus guidelines suggest that antiemetics from a class different than given as prophylaxis should be administered. To decrease the incidence of PONV and increase the quality of care, the importance of the implementation of institutional-level guidelines and protocols as well as assessment of PONV prophylaxis and PONV incidence is highly recommended.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田様的应助被不舍天真采纳,获得10
刚刚
香蕉觅云的应助被科研通管家采纳,获得10
刚刚
刚刚
华仔的应助被科研通管家采纳,获得10
刚刚
molihuakai的应助被科研通管家采纳,获得10
刚刚
刚刚
wanci的应助被科研通管家采纳,获得30
刚刚
无极微光的应助被科研通管家采纳,获得20
刚刚
Ava的应助被科研通管家采纳,获得10
1秒前
1秒前
Orange的应助被科研通管家采纳,获得10
1秒前
1秒前
烟花的应助被科研通管家采纳,获得10
1秒前
1秒前
我是老大的应助被科研通管家采纳,获得10
1秒前
科研小牛完成签到,获得积分10
1秒前
evildoer发布了新的文献求助10
1秒前
儒雅的蓝天完成签到,获得积分10
2秒前
3秒前
4秒前
4秒前
爆米花的应助被xm采纳,获得10
5秒前
秋彤完成签到,获得积分20
5秒前
zaka发布了新的文献求助10
5秒前
纯真忆安发布了新的文献求助10
6秒前
田様的应助被steins采纳,获得10
6秒前
7秒前
AAA发布了新的文献求助10
7秒前
光亮白开水完成签到 ,获得积分10
7秒前
7秒前
7秒前
秋风的应助被lhj采纳,获得10
8秒前
情怀的应助被刻苦夜雪采纳,获得10
8秒前
8秒前
221发布了新的文献求助10
9秒前
9秒前
1134117009发布了新的文献求助10
9秒前
SZ完成签到,获得积分10
10秒前
传奇3的应助被Steven采纳,获得80
10秒前
Kenny发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163922
求助须知:如何正确求助?哪些是违规求助? 9557995
关于积分的说明 21743022
捐赠科研通 7754548
什么是DOI,文献DOI怎么找? 3428401
关于科研通互助平台的介绍 2553053
邀请新用户注册赠送积分活动 2473008